PBS Of Australia To Get Advice On Erbitux, Gene-Testing Implications
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaceutical Benefits Advisory Committee is set to decide this week whether to recommend covering Merck Serono's Erbitux (cetuximab) cancer drug